Elise Reuter

Just 61% of hospitals surveyed evaluated models for accuracy on their own data, and less than half evaluated the models for bias.

Kevin Sayer said at the J.P. Morgan Healthcare Conference that Dexcom also expects to release a 15-day glucose sensor in the second half of the year.

Hologic stopped manufacturing the device after reports of serious adverse events in patients who had the markers implanted in breast tissue.

New documents clarify how the FDA plans to regulate AI-enabled devices, experts say, but several important questions remain around insurance coverage and generative AI.

CEO Robert Ford also plans to expand sales of the company’s Lingo over-the-counter glucose sensors after a limited rollout.

Brenner, who worked in the FDA’s Center for Devices and Radiological Health, will take the helm of the agency until a new leader is confirmed.

Brenner, who has worked in the FDA’s Center for Devices and Radiological Health, will lead the agency until a permanent commissioner is confirmed.

The website changes raise concerns about “the interference of politics with the study and the practice” of science and medicine, a physician said.

Investment firm Bridgefield Capital will buy the segment, which includes cardiac resuscitation and emergency care devices, for an undisclosed amount.

Stryker to sell spinal implants business Globus' planned acquisition of NuVasive could face challenges seen in past mergers of spine companies. ·